MS is an autoimmune disease that affects the central nervous system by destroying myelin, the protective fatty tissue covering nerve fibers. Without myelin, nerves are unable to transmit signals to and from the brain. It is estimated that more than 2.5 million people worldwide are affected by MS, with more than 400,000 diagnosed in the
John Ryals, president and CEO of Metabolon, said the company hopes to use metabolomics to find biomarkers that will determine a cause for the disease and that can be used to create a definitive diagnostic tool for it.
Financial terms of the research were not disclosed.